Insights

Targeted age solutions AB-BIOTICS is actively developing probiotic solutions for older adults, presenting a clear opportunity to upsell targeted products to senior-focused healthcare providers, retirement communities, and age-related wellness channels.

Women’s health expansion With the launch of the Gyntima women's health range and research supporting estrogen activity, there is potential to pursue partnerships with OB/GYN clinics, menopause clinics, and consumer brands focusing on women’s health and functional foods.

Cholesterol bold entry The Chinese market entry through Wonderlab for cholesterol-controlling probiotics indicates opportunities to collaborate with Asian distributors, importers, and dietary supplement brands seeking evidence-backed cholesterol management solutions.

Infant and child nutrition AB-BIOTICS has already introduced infant nutrition products and partnered for child-focused formats, suggesting channels with pediatric clinics, family wellness retailers, and global kids’ nutrition brands as potential partners.

Regulatory and global reach A global footprint with regulatory support across supplements, functional foods, OTC, and medical applications enables cross-border sales discussions with multinationals seeking probiotic platforms, market access, and compliant product rollouts.

Similar companies to AB-BIOTICS

AB-BIOTICS Tech Stack

AB-BIOTICS uses 8 technology products and services including Hotjar, HubSpot Analytics, Linkedin Insight Tag, and more. Explore AB-BIOTICS's tech stack below.

Media & News

AB-BIOTICS's Email Address Formats

AB-BIOTICS uses at least 4 email formats:
AB-BIOTICS Email FormatsExamplePercentage
Last@ab-biotics.comDoe@ab-biotics.com
56%
Middle@ab-biotics.comMichael@ab-biotics.com
28%
First@ab-biotics.comJohn@ab-biotics.com
12%
F-Last@ab-biotics.comJ-Doe@ab-biotics.com
4%

Frequently Asked Questions

What is AB-BIOTICS's official website and social media links?

Minus sign iconPlus sign icon
AB-BIOTICS's official website is ab-biotics.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does AB-BIOTICS generate?

Minus sign iconPlus sign icon
As of August 2026, AB-BIOTICS's annual revenue is estimated to be $10M - $25M.

What is AB-BIOTICS's SIC code and NAICS code?

Minus sign iconPlus sign icon
AB-BIOTICS's SIC code is 8731 - Commercial Physical and Biological Research and NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does AB-BIOTICS have currently?

Minus sign iconPlus sign icon
As of August 2026, AB-BIOTICS has approximately 89 employees across 3 continents, including Europe, Asia and North America. Key team members include Chief Executive Officer: M. D., Chief Financial Officer: M. N. and Chief Business Development Officer: J. R. Explore AB-BIOTICS's employee directory with LeadIQ.

What industry does AB-BIOTICS belong to?

Minus sign iconPlus sign icon
AB-BIOTICS operates in the Biotechnology Research industry.

What technology does AB-BIOTICS use?

Minus sign iconPlus sign icon
AB-BIOTICS's tech stack includes Hotjar, HubSpot Analytics, Linkedin Insight Tag, iCIMS, WordPress, Microsoft 365, Adobe Creative Suite and Piwik PRO Core.

What is AB-BIOTICS's email format?

Minus sign iconPlus sign icon
AB-BIOTICS's email format typically follows the pattern of Last@ab-biotics.com. Find more AB-BIOTICS email formats with LeadIQ.

How much funding has AB-BIOTICS raised to date?

Minus sign iconPlus sign icon
As of August 2026, AB-BIOTICS has raised $709K in funding. The last funding round occurred on Oct 01, 2017 for $59K.

When was AB-BIOTICS founded?

Minus sign iconPlus sign icon
AB-BIOTICS was founded in 2004.
AB-BIOTICS logo

AB-BIOTICS

Biotechnology ResearchCatalonia, Spain51-200 Employees

AB-BIOTICS is a biotechnology company specializing in probiotics, developing strains, blends, and market-ready probiotic products supported by scientific documentation. Headquartered in Catalonia, Spain, at 3 Avinguda Can Fatjó Dels Aurons San Cugat Del Vallés, it maintains a global footprint and provides regulatory support across supplements, functional foods, OTC, and medical applications. The company employs between 51 and 200 people. Its recent activities include partnerships and product launches across infant nutrition and women's health, and expansion into the Chinese market. Notable developments include the Wonderlab collaboration to enter China, the Gyntima women's health range, and the Frezylac infant formula with Frezyderm; AB-BIOTICS is described as a Kaneka company in industry reports. Reported revenue is in the range of $10 million to $25 million.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2004
Employees
51-200

Section iconFunding & Financials

  • $709K

    AB-BIOTICS has raised a total of $709K of funding over 3 rounds. Their latest funding round was raised on Oct 01, 2017 in the amount of $59K as a Grant.

  • $10M - $25M

    AB-BIOTICS's revenue is estimated to be in the range of $10M - $25M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.